Format

Send to

Choose Destination
J Oncol Pract. 2016 Jul;12(7):633-4. doi: 10.1200/JOP.2016.014308.

Allogeneic Hematopoietic Stem-Cell Transplantation in Myelofibrosis: Key Messages for Clinical Practice in the Era of Janus Kinase 1/2 Inhibitors.

Author information

1
Thammasat University, Bangkok, Thailand, and The University of Texas MD Anderson Cancer Center, Houston, TX.
2
Thammasat University, Bangkok, Thailand, and The University of Texas MD Anderson Cancer Center, Houston, TX upopat@mdanderson.org.
PMID:
27407159
DOI:
10.1200/JOP.2016.014308
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center